Matthew Jarboe
Net Worth

Last updated:

What is Matthew Jarboe net worth?

The estimated net worth of Mr. Matthew Jarboe is at least $11,390,548 as of 23 Dec 2022. He owns shares worth $3,557,391 as insider, has earned $6,018,037 from insider trading and has received compensation worth at least $1,815,120 in Paragon 28, Inc..

What is the salary of Matthew Jarboe?

Mr. Matthew Jarboe salary is $605,040 per year as Chief Commercial Officer in Paragon 28, Inc..

How old is Matthew Jarboe?

Mr. Matthew Jarboe is 42 years old, born in 1983.

What stocks does Matthew Jarboe currently own?

As insider, Mr. Matthew Jarboe owns shares in one company:

Company Title Shares Price per share Total value
Paragon 28, Inc. (FNA) Chief Commercial Officer 271,764 $13.09 $3,557,391

What does Paragon 28, Inc. do?

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Matthew Jarboe insider trading

Paragon 28, Inc.

Mr. Matthew Jarboe has made 7 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 35,110 units of FNA stock worth $734,677 on 23 Dec 2022.

The largest trade he's ever made was exercising 72,432 units of FNA stock on 15 Jul 2022. As of 23 Dec 2022 he still owns at least 271,764 units of FNA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 35,110 $20.93 $734,677
Option
Common Stock 35,110 $1.2 $42,132
Option
Stock Option (Right to Buy) 35,110 $1.2 $42,132
Option
Stock Option (Right to Buy) 10,023 $0.6 $6,014
Option
Stock Option (Right to Buy) 14,890 $1.2 $17,868
Option
Common Stock 10,023 $0.6 $6,014
Option
Common Stock 14,890 $1.2 $17,868
Sale
Common Stock 24,913 $20.91 $521,006
Option
Stock Option (Right to Buy) 62,099 $0.6 $37,259
Sale
Common Stock 62,099 $20.91 $1,298,676
Option
Common Stock 62,099 $0.6 $37,259
Option
Stock Option (Right to Buy) 2,878 $0.6 $1,727
Sale
Common Stock 27,878 $20.94 $583,682
Option
Common Stock 2,878 $0.6 $1,727
Sale
Common Stock 72,432 $19.02 $1,377,874
Sale
Common Stock 13,679 $19 $259,928
Sale
Common Stock 63,889 $19.44 $1,242,194

Paragon 28 key executives

Paragon 28, Inc. executives and other stock owners filed with the SEC: